Translating Deep Human Biology into Revelationary New Therapies

Drug discovery and development anchored in human genetic target validation


We turn drug development on its head

We start in humans. We start with genomics.

Connect drug targets with diseases

We identify and validate potential drug targets

We have sequenced every gene of the human genome in thousands of individuals, and measured hundreds of thousands of intermediate biomarkers, and can now identify and validate all potential drug targets for any disease for which we have phenotype information.

There are approximately 25,000 genes in the human genome, and approximately 20,000 different proteins in the human body. Accordingly, there are no more than 20,000 theoretical potential drug targets in the traditional sense. As we have sequenced all ~25,000 genes in thousands of individuals, we can connect the correct drug target with the correct disease state to cure diseases that cause individual suffering and significant societal burden.

G3T's Platform

G3T's pipeline

Using our unique approach we have already identified multiple novel drug candidates, several of which  are currently in in-vitro studies.

View our pipeline


Making a difference with multiomics